154 related articles for article (PubMed ID: 32559765)
21. Formation of bradykinin: a major contributor to the innate inflammatory response.
Joseph K; Kaplan AP
Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
[TBL] [Abstract][Full Text] [Related]
22. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
Joseph K; Shibayama Y; Nakazawa Y; Peerschke EI; Ghebrehiwet B; Kaplan AP
Immunopharmacology; 1999 Sep; 43(2-3):203-10. PubMed ID: 10596854
[TBL] [Abstract][Full Text] [Related]
23. Activation of the plasma kinin forming cascade along cell surfaces.
Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B
Int Arch Allergy Immunol; 2001; 124(1-3):339-42. PubMed ID: 11307009
[TBL] [Abstract][Full Text] [Related]
24. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
Mutch NJ; Waters EK; Morrissey JH
J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
[TBL] [Abstract][Full Text] [Related]
25. Subcellular targeting of multiligand-binding protein gC1qR.
Dedio J; Renné T; Weisser M; Müller-Esterl W
Immunopharmacology; 1999 Dec; 45(1-3):1-5. PubMed ID: 10614982
[TBL] [Abstract][Full Text] [Related]
26. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
[TBL] [Abstract][Full Text] [Related]
27. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
[TBL] [Abstract][Full Text] [Related]
28. Targeting gC1qR domains for therapy against infection and inflammation.
Ghebrehiwet B; Jesty J; Vinayagasundaram R; Vinayagasundaram U; Ji Y; Valentino A; Tumma N; Hosszu KH; Peerschke EI
Adv Exp Med Biol; 2013; 735():97-110. PubMed ID: 23402021
[TBL] [Abstract][Full Text] [Related]
29. Zinc induces exposure of hydrophobic sites in the C-terminal domain of gC1q-R/p33.
Kumar R; Peerschke EI; Ghebrehiwet B
Mol Immunol; 2002 Sep; 39(1-2):69-75. PubMed ID: 12213329
[TBL] [Abstract][Full Text] [Related]
30. The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor.
Lim BL; Reid KB; Ghebrehiwet B; Peerschke EI; Leigh LA; Preissner KT
J Biol Chem; 1996 Oct; 271(43):26739-44. PubMed ID: 8900153
[TBL] [Abstract][Full Text] [Related]
31. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
[TBL] [Abstract][Full Text] [Related]
32. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
Mahdi F; Shariat-Madar Z; Schmaier AH
J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
[TBL] [Abstract][Full Text] [Related]
33. Coagulation factor XII protease domain crystal structure.
Pathak M; Wilmann P; Awford J; Li C; Hamad BK; Fischer PM; Dreveny I; Dekker LV; Emsley J
J Thromb Haemost; 2015 Apr; 13(4):580-91. PubMed ID: 25604127
[TBL] [Abstract][Full Text] [Related]
34. Protease activity in single-chain prekallikrein.
Ivanov I; Verhamme IM; Sun MF; Mohammed B; Cheng Q; Matafonov A; Dickeson SK; Joseph K; Kaplan AP; Gailani D
Blood; 2020 Feb; 135(8):558-567. PubMed ID: 31800958
[TBL] [Abstract][Full Text] [Related]
35. The assembly and activation of kinin-forming systems on the surface of human U-937 macrophage-like cells.
Barbasz A; Kozik A
Biol Chem; 2009 Mar; 390(3):269-75. PubMed ID: 19090728
[TBL] [Abstract][Full Text] [Related]
36. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells.
Mahdi F; Shariat-Madar Z; Todd RF; Figueroa CD; Schmaier AH
Blood; 2001 Apr; 97(8):2342-50. PubMed ID: 11290596
[TBL] [Abstract][Full Text] [Related]
37. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation.
Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B; Silverberg M
Adv Immunol; 1997; 66():225-72. PubMed ID: 9328643
[No Abstract] [Full Text] [Related]
38. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
Gallimore MJ; Harris SL; Jones DW; Winter M
Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
[TBL] [Abstract][Full Text] [Related]
39. Structure of the third intracellular loop of the vasopressin V2 receptor and conformational changes upon binding to gC1qR.
Bellot G; Granier S; Bourguet W; Seyer R; Rahmeh R; Mouillac B; Pascal R; Mendre C; Déméné H
J Mol Biol; 2009 May; 388(3):491-507. PubMed ID: 19285506
[TBL] [Abstract][Full Text] [Related]
40. The contribution of gC1qR/p33 in infection and inflammation.
Peerschke EI; Ghebrehiwet B
Immunobiology; 2007; 212(4-5):333-42. PubMed ID: 17544818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
